IL-4 and IL-13 play key roles in the development of AD symptoms, namely, decreased integrity and barrier function of the skin and level of peptides associated with antibiotics, which further cause skin barrier abnormalities such as pruritus, xerosis, blister, pigmentation, and lichenification8. The gene discussed is IL13; the disease is Pruritus.